Palatin Technologies (PTN)

Create an Alert
0.60 -0.03  -4.31%   AMEX Jun 19, 5:00PM BATS Real time Currency in USD

Palatin Technologies R&D Expense Quarterly:

2.945M for March 31, 2013
View Full Chart

Palatin Technologies R&D Expense Quarterly Chart

    Palatin Technologies Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 2.945M
    Dec. 31, 2012 2.446M
    Sept. 30, 2012 2.343M
    June 30, 2012 4.130M
    March 31, 2012 4.706M
    Dec. 31, 2011 2.693M
    Sept. 30, 2011 2.284M
    June 30, 2011 3.217M
    March 31, 2011 1.722M
    Dec. 31, 2010 1.984M
    Sept. 30, 2010 3.453M
    June 30, 2010 3.554M
    March 31, 2010 3.357M
    Dec. 31, 2009 2.713M
    Sept. 30, 2009 2.670M
    June 30, 2009 3.045M
    March 31, 2009 3.814M
    Dec. 31, 2008 2.840M
    Sept. 30, 2008 3.658M
    June 30, 2008 4.892M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    PTN R&D Expense Quarterly Benchmarks

    Companies
    SurModics 3.774M
    Karver International
    Optigenex

    PTN R&D Expense Quarterly Rankings

    Overall 92nd percentile
    1260 of 16782
    Sector 73rd percentile
    369 of 1410 in Healthcare
    Industry 83rd percentile
    21 of 130 in Diagnostics & Research

    PTN R&D Expense Quarterly Range, Past 5 Years

    Minimum 1.722M Mar 2011
    Maximum 4.891M Jun 2008
    Average 3.123M

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');